PCBD1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PCBD1 monoclonal antibodies for multiple research applications. PCBD1 Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PCBD1, or pterin-4-alpha-carbinolamine dehydratase, is essential in tetrahydrobiopterin biosynthesis, a cofactor necessary for producing neurotransmitters like dopamine and serotonin. PCBD1 participates in nitric oxide synthase regulation, making it significant for both neurological and cardiovascular functions. Research focused on PCBD1 continues to reveal new insights about its role in neurological disorders and cardiovascular diseases. Scientists worldwide utilize PCBD1 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification in experiments. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for various medical conditions.